A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology
Status:
Completed
Trial end date:
2021-10-27
Target enrollment:
Participant gender:
Summary
Laser treatment (LT) is the first-line treatment for Vascular Pathology. However even when LT
is based on the selective photothermolysis it causes the first-degree burns. While being
typically benign by affecting only the epidermis, or outer layer of skin, the burn site is
remaining red, dry, and very painful. As Haemoblock contains nanoparticles of silver and is
known for both bactericidal and bacteriostatic effects, it likely decreases the potential for
infection postoperatively. Furthermore, after fibrin replaces the superficial structure
"Hemoblock-albumin", the polyacrylate matrix is plasmolyzed which initiates the cascade of
signals required for the tissue regeneration processes. Objective of the study was to examine
the effect of the Regenerative Solution "Hemoblock" in lowering postoperative complications
in children diagnosed with Vascular Pathology undergoing a laser surgery if delivered with
transdermal patches.